The negative correlation between total sRAGE and AGE in non-NASH NAFLD but, lack of correlation in patients with NASH (Table 2) may be attributed to other RAGE ligands playing a role in RAGE pathway activation as NAFLD progresses to NASH. Here, AGER is linked to metabolic dysfunction-associated steatotic liver disease.